These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 1019213
1. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline]. Terhaag B, Förster W. Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213 [No Abstract] [Full Text] [Related]
2. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol]. Terhaag B, Förster W, Mest HJ, Schrör K. Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278 [No Abstract] [Full Text] [Related]
3. [Inhibition of adrenergic beta receptors by N,N'-bis-[3-(2'ethoxyphenoxy)-2-hydroxypropyl]-ethylenediamine (Falirytmin) as compared to propranolol]. Mentz P, Bayer BL, Wartner U, Terhaag B, Förster W. Pharmazie; 1976; 31(9):640-2. PubMed ID: 14343 [No Abstract] [Full Text] [Related]
5. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects]. Femmer K, Grünheid K. Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276 [No Abstract] [Full Text] [Related]
6. [New method for producing atrial arrhythmia by aconitine (cup method) and evaluation of antifibrillatory activity of ajmaline, propranolol, procainamide and quinidine]. Nakayama K, Kumakura S. Nihon Yakurigaku Zasshi; 1968 May 20; 64(3):385-92. PubMed ID: 5749309 [No Abstract] [Full Text] [Related]
8. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine. Parmley WW, Braunwald E. J Pharmacol Exp Ther; 1967 Oct 20; 158(1):11-21. PubMed ID: 6054071 [No Abstract] [Full Text] [Related]
9. [Comparative characteristics of the activity of lithium preparations and anti-arrhythmia agents in strophanthin, calcium chloride and barium chloride arrhythmias in an experiment]. Galenko-Iaroshevskiĭ PA, Tikhonov AV. Farmakol Toksikol; 1985 Oct 20; 48(2):64-8. PubMed ID: 3996574 [Abstract] [Full Text] [Related]
11. The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat. Somberg JC, Bounous H, Levitt B. Eur J Pharmacol; 1979 Feb 15; 54(1-2):161-6. PubMed ID: 421737 [No Abstract] [Full Text] [Related]
12. Antiarrhythmic effect of some naphthylalkylamine derivatives. Hadházy P, Kecskeméti V, Vizi ES, Illés P. Acta Physiol Acad Sci Hung; 1968 Feb 15; 33(2):185-95. PubMed ID: 5679793 [No Abstract] [Full Text] [Related]
13. Antiarrhythmic effect of aprindine on several types of ventricular arrhythmias. Ueda M, Kimoto S, Matsuda S, Kawakami M, Mroishige E, Matsumura S, Takeda H. Jpn J Pharmacol; 1975 Oct 15; 25(5):549-61. PubMed ID: 1221137 [Abstract] [Full Text] [Related]
15. [Antiarrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS -15) on experimental arrhythmia induced by aconitin, ouabain, calcium chloride and barium chloride]. Femmer K, Poppe H, Heer S, Bartsch R. Pharmazie; 1985 Dec 15; 40(12):836-40. PubMed ID: 3841597 [Abstract] [Full Text] [Related]
16. [The influence of antiarrhythmic drugs on the exercise-ecg (author's transl)]. Raff U, Hepp A. Z Kardiol; 1977 Feb 15; 66(2):61-5. PubMed ID: 842073 [Abstract] [Full Text] [Related]
17. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats]. Ammar EM, Kudrin AN. Farmakol Toksikol; 1969 Feb 15; 32(5):566-70. PubMed ID: 5364670 [No Abstract] [Full Text] [Related]